BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, March 18, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Sep. 29, 2004
View Archived Issues
Qiagen Pays $28.5M Cash For Molecular Staging Technology
Qiagen NV is paying $28.5 million in cash to acquire whole-genome amplification technology from Molecular Staging Inc. (BioWorld International)
Read More
ExonHit Therapeutics' ALS Drug Fails In Phase III Trial
Read More
Cells' Strategy For Rejuvenation Boosts Stem Cell Therapy Hope
Read More
France Gives Green Light To Embryonic Stem Cell Imports
Read More
Public, Private Sectors At Odds Over German Biotech Direction
Read More
Physiomics Enters Deal With Bayer, Eyes IPO On AIM Index
Read More
Other News To Note
Read More